Tapewire

Nasdaq · USD

JSPR

Jasper Therapeutics, Inc.

Export transactions ↓
Tapewire entity
7588
SEC CIK
0001788028
Parsed reports
158

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 31, 2026 Filed Aug 4, 2026 20:10 UTC GrantStock Option (Right to Buy · Derivative 7,500 $0.00 Strike: $0.63 $0.00
Disclosure

SEC source: 0001213900-26-085188 · ownership.xml · derivative · entry 1

Shizuru Judith Anne · CIK 0001883000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2036-07-31

F1 · derivative.exercise_date: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.

F1 · derivative.expiration_date: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.

Read SEC document
July 31, 2026 Filed Aug 4, 2026 20:10 UTC GrantStock Option (Right to Buy · Derivative 7,500 $0.00 Strike: $0.63 $0.00
Disclosure

SEC source: 0001213900-26-085190 · ownership.xml · derivative · entry 1

Crutcher Patrick J · CIK 0001754540 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2036-07-31

F1 · derivative.exercise_date: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.

F1 · derivative.expiration_date: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.

Read SEC document
July 31, 2026 Filed Aug 4, 2026 20:11 UTC GrantStock Option (Right to Buy · Derivative 7,500 $0.00 Strike: $0.63 $0.00
Disclosure

SEC source: 0001213900-26-085192 · ownership.xml · derivative · entry 1

WIGGANS THOMAS G · CIK 0001208907 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2036-07-31

F1 · derivative.exercise_date: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.

F1 · derivative.expiration_date: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.

Read SEC document
July 31, 2026 Filed Aug 4, 2026 20:10 UTC GrantStock Option (Right to Buy · Derivative 7,500 $0.00 Strike: $0.63 $0.00
Disclosure

SEC source: 0001213900-26-085189 · ownership.xml · derivative · entry 1

EMSTER KURT VON · CIK 0001252524 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2036-07-31

F1 · derivative.exercise_date: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.

F1 · derivative.expiration_date: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.

Read SEC document
July 31, 2026 Filed Aug 4, 2026 20:10 UTC GrantStock Option (Right to Buy · Derivative 7,500 $0.00 Strike: $0.63 $0.00
Disclosure

SEC source: 0001213900-26-085191 · ownership.xml · derivative · entry 1

Lucas Svetlana · CIK 0001781292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2036-07-31

F1 · derivative.exercise_date: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.

F1 · derivative.expiration_date: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.

Read SEC document
July 20, 2026 Filed Jul 21, 2026 00:38 UTC PurchaseNon-Voting Convertible Preferred Stock · Derivative 888 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-079764 · ownership.xml · derivative · entry 2

Crutcher Patrick J · CIK 0001754540 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 888

Underlying: Voting Common Stock · 888 shares

Expires not disclosed

F2 · derivative.exercise_price: On July 16, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold the referenced shares of preferred stock to the Reporting Person in a private placement, which closed on July 20, 2026.

F3 · derivative.exercise_price: On the third business day following the receipt of stockholder approval of the conversion of the preferred stock, each share of preferred stock shall automatically convert into 61 shares of the Issuer's voting common stock ("Voting Common Stock"), subject to certain limitations, including that a holder of preferred stock is prohibited from converting shares of preferred stock into shares of Voting Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 4.9% and 19.9%) of the total number of shares of Voting Common Stock issued and outstanding immediately after giving effect to such conversion. The preferred stock has no expiration date.

F2 · shares: On July 16, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold the referenced shares of preferred stock to the Reporting Person in a private placement, which closed on July 20, 2026.

F3 · shares: On the third business day following the receipt of stockholder approval of the conversion of the preferred stock, each share of preferred stock shall automatically convert into 61 shares of the Issuer's voting common stock ("Voting Common Stock"), subject to certain limitations, including that a holder of preferred stock is prohibited from converting shares of preferred stock into shares of Voting Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 4.9% and 19.9%) of the total number of shares of Voting Common Stock issued and outstanding immediately after giving effect to such conversion. The preferred stock has no expiration date.

F2 · price: On July 16, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold the referenced shares of preferred stock to the Reporting Person in a private placement, which closed on July 20, 2026.

F3 · price: On the third business day following the receipt of stockholder approval of the conversion of the preferred stock, each share of preferred stock shall automatically convert into 61 shares of the Issuer's voting common stock ("Voting Common Stock"), subject to certain limitations, including that a holder of preferred stock is prohibited from converting shares of preferred stock into shares of Voting Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 4.9% and 19.9%) of the total number of shares of Voting Common Stock issued and outstanding immediately after giving effect to such conversion. The preferred stock has no expiration date.

F2 · derivative.exercise_date: On July 16, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold the referenced shares of preferred stock to the Reporting Person in a private placement, which closed on July 20, 2026.

F3 · derivative.exercise_date: On the third business day following the receipt of stockholder approval of the conversion of the preferred stock, each share of preferred stock shall automatically convert into 61 shares of the Issuer's voting common stock ("Voting Common Stock"), subject to certain limitations, including that a holder of preferred stock is prohibited from converting shares of preferred stock into shares of Voting Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 4.9% and 19.9%) of the total number of shares of Voting Common Stock issued and outstanding immediately after giving effect to such conversion. The preferred stock has no expiration date.

F2 · derivative.expiration_date: On July 16, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold the referenced shares of preferred stock to the Reporting Person in a private placement, which closed on July 20, 2026.

F3 · derivative.expiration_date: On the third business day following the receipt of stockholder approval of the conversion of the preferred stock, each share of preferred stock shall automatically convert into 61 shares of the Issuer's voting common stock ("Voting Common Stock"), subject to certain limitations, including that a holder of preferred stock is prohibited from converting shares of preferred stock into shares of Voting Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 4.9% and 19.9%) of the total number of shares of Voting Common Stock issued and outstanding immediately after giving effect to such conversion. The preferred stock has no expiration date.

Read SEC document
July 20, 2026 Filed Jul 22, 2026 23:10 UTC
Ros Matthew EChief Operating Officer
PurchaseNon-Voting Convertible Preferred Stock · Derivative 881 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-26-080525 · ownership.xml · derivative · entry 1

Ros Matthew E · CIK 0001461613 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 881

Underlying: Voting Common Stock · 53,741 shares

Expires not disclosed

F1 · derivative.exercise_price: On July 16, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold the referenced shares of preferred stock to the Reporting Person in a private placement, which closed on July 20, 2026.

F2 · derivative.exercise_price: On the third business day following the receipt of stockholder approval of the conversion of the preferred stock, each share of preferred stock shall automatically convert into 61 shares of the Issuer's voting common stock ("Voting Common Stock"), subject to certain limitations, including that a holder of preferred stock is prohibited from converting shares of preferred stock into shares of Voting Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 4.9% and 19.9%) of the total number of shares of Voting Common Stock issued and outstanding immediately after giving effect to such conversion. The preferred stock has no expiration date.

F1 · shares: On July 16, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold the referenced shares of preferred stock to the Reporting Person in a private placement, which closed on July 20, 2026.

F2 · shares: On the third business day following the receipt of stockholder approval of the conversion of the preferred stock, each share of preferred stock shall automatically convert into 61 shares of the Issuer's voting common stock ("Voting Common Stock"), subject to certain limitations, including that a holder of preferred stock is prohibited from converting shares of preferred stock into shares of Voting Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 4.9% and 19.9%) of the total number of shares of Voting Common Stock issued and outstanding immediately after giving effect to such conversion. The preferred stock has no expiration date.

F1 · price: On July 16, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold the referenced shares of preferred stock to the Reporting Person in a private placement, which closed on July 20, 2026.

F2 · price: On the third business day following the receipt of stockholder approval of the conversion of the preferred stock, each share of preferred stock shall automatically convert into 61 shares of the Issuer's voting common stock ("Voting Common Stock"), subject to certain limitations, including that a holder of preferred stock is prohibited from converting shares of preferred stock into shares of Voting Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 4.9% and 19.9%) of the total number of shares of Voting Common Stock issued and outstanding immediately after giving effect to such conversion. The preferred stock has no expiration date.

F1 · derivative.exercise_date: On July 16, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold the referenced shares of preferred stock to the Reporting Person in a private placement, which closed on July 20, 2026.

F2 · derivative.exercise_date: On the third business day following the receipt of stockholder approval of the conversion of the preferred stock, each share of preferred stock shall automatically convert into 61 shares of the Issuer's voting common stock ("Voting Common Stock"), subject to certain limitations, including that a holder of preferred stock is prohibited from converting shares of preferred stock into shares of Voting Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 4.9% and 19.9%) of the total number of shares of Voting Common Stock issued and outstanding immediately after giving effect to such conversion. The preferred stock has no expiration date.

F1 · derivative.expiration_date: On July 16, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold the referenced shares of preferred stock to the Reporting Person in a private placement, which closed on July 20, 2026.

F2 · derivative.expiration_date: On the third business day following the receipt of stockholder approval of the conversion of the preferred stock, each share of preferred stock shall automatically convert into 61 shares of the Issuer's voting common stock ("Voting Common Stock"), subject to certain limitations, including that a holder of preferred stock is prohibited from converting shares of preferred stock into shares of Voting Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 4.9% and 19.9%) of the total number of shares of Voting Common Stock issued and outstanding immediately after giving effect to such conversion. The preferred stock has no expiration date.

Read SEC document
July 16, 2026 Filed Jul 21, 2026 00:38 UTC GrantStock Option (Right to Buy · Derivative 15,000 $0.00 Strike: $0.77 $0.00
Disclosure

SEC source: 0001213900-26-079764 · ownership.xml · derivative · entry 1

Crutcher Patrick J · CIK 0001754540 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Voting Common Stock · 15,000 shares

Expires not disclosed

F1 · derivative.exercise_date: The shares shall vest as follows: 25% on the one-year anniversary of the date of grant and the remaining shares shall vest in equal monthly installments over the next 36 months until fully vested, subject to continuous service through each applicable vesting date.

F1 · derivative.expiration_date: The shares shall vest as follows: 25% on the one-year anniversary of the date of grant and the remaining shares shall vest in equal monthly installments over the next 36 months until fully vested, subject to continuous service through each applicable vesting date.

Read SEC document
February 06, 2026 Filed Feb 10, 2026 16:00 UTC
Mahal Jeetinder SinghDirector · CEO and President
GrantStock Option (right to buy) · Derivative 500,000 $0.00 Strike: $1.35 $0.00
Disclosure

SEC source: 0001213900-26-014244 · ownership.xml · derivative · entry 1

Mahal Jeetinder Singh · CIK 0001882877 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Voting Common Stock · 500,000 shares

Expires 2036-02-06

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on February 6, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 19:30 UTC
MARTELL RONDirector · President, CEO and Director
GrantStock Option (right to buy) · Derivative 234,000 $0.00 Strike: $1.84 $0.00
Disclosure

SEC source: 0001213900-26-001385 · ownership.xml · derivative · entry 1

MARTELL RON · CIK 0001177079 · Director · President, CEO and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,000

Underlying: Voting Common Stock · 234,000 shares

Expires 2036-01-02

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on January 2, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 19:30 UTC
Mahal Jeetinder SinghChief Operating Officer
GrantStock Option (right to buy) · Derivative 90,000 $0.00 Strike: $1.84 $0.00
Disclosure

SEC source: 0001213900-26-001383 · ownership.xml · derivative · entry 1

Mahal Jeetinder Singh · CIK 0001882877 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Voting Common Stock · 90,000 shares

Expires 2036-01-02

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on January 2, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 19:30 UTC
CROSS HERBChief Financial Officer
GrantStock Option (right to buy) · Derivative 90,000 $0.00 Strike: $1.84 $0.00
Disclosure

SEC source: 0001213900-26-001382 · ownership.xml · derivative · entry 1

CROSS HERB · CIK 0001230721 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Voting Common Stock · 90,000 shares

Expires 2036-01-02

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on January 2, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 20:01 UTC PurchaseCommon Stock Warrant (right to buy) · Derivative 41,000 Not disclosed Strike: $2.92 Not disclosed
Disclosure

SEC source: 0001213900-25-091096 · ownership.xml · derivative · entry 2

Shizuru Judith Anne · CIK 0001883000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,000

Underlying: Voting Common Stock · 41,000 shares

Expires 2030-03-22

F1 · price: Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 20:01 UTC PurchaseVoting Common Stock 41,000 $2.43 $99,630.00
Disclosure

SEC source: 0001213900-25-091096 · ownership.xml · nonDerivative · entry 1

Shizuru Judith Anne · CIK 0001883000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,901

F1 · price: Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 16:01 UTC
MARTELL RONDirector · President and CEO
PurchaseCommon Stock Warrant (right to buy) · Derivative 41,000 Not disclosed Strike: $2.92 Not disclosed
Disclosure

SEC source: 0001213900-25-091099 · ownership.xml · derivative · entry 2

MARTELL RON · CIK 0001177079 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,000

Underlying: Voting Common Stock · 41,000 shares

Expires 2030-03-22

F1 · price: Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 16:01 UTC
MARTELL RONDirector · President and CEO
PurchaseVoting Common Stock 41,000 $2.43 $99,630.00
Disclosure

SEC source: 0001213900-25-091099 · ownership.xml · nonDerivative · entry 1

MARTELL RON · CIK 0001177079 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,118

F1 · price: Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 20:01 UTC PurchaseCommon Stock Warrant (right to buy) · Derivative 41,000 Not disclosed Strike: $2.92 Not disclosed
Disclosure

SEC source: 0001213900-25-091105 · ownership.xml · derivative · entry 3

WIGGANS THOMAS G · CIK 0001208907 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wiggans Living Trust

Disclosed balance after: 41,000

Underlying: Voting Common Stock · 41,000 shares

Expires 2030-03-22

F1 · price: Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 20:01 UTC PurchaseVoting Common Stock 41,000 $2.43 $99,630.00
Disclosure

SEC source: 0001213900-25-091105 · ownership.xml · nonDerivative · entry 1

WIGGANS THOMAS G · CIK 0001208907 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Wiggans Living Trust

Disclosed balance after: 41,000

F1 · price: Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 20:01 UTC PurchaseCommon Stock Warrant (right to buy) · Derivative 20,000 Not disclosed Strike: $2.92 Not disclosed
Disclosure

SEC source: 0001213900-25-091104 · ownership.xml · derivative · entry 2

Lucas Svetlana · CIK 0001781292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Voting Common Stock · 20,000 shares

Expires 2030-03-22

F1 · price: Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.

Read SEC document
September 22, 2025 Filed Sep 24, 2025 20:01 UTC PurchaseVoting Common Stock 20,000 $2.43 $48,600.00
Disclosure

SEC source: 0001213900-25-091104 · ownership.xml · nonDerivative · entry 1

Lucas Svetlana · CIK 0001781292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

F1 · price: Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.

Read SEC document
July 03, 2025 Filed Jul 3, 2025 20:24 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $6.77 $0.00
Disclosure

SEC source: 0001213900-25-061500 · ownership.xml · derivative · entry 1

Shizuru Judith Anne · CIK 0001883000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2035-07-03

F1 · shares: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders.

Read SEC document
July 03, 2025 Filed Jul 3, 2025 20:25 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $6.77 $0.00
Disclosure

SEC source: 0001213900-25-061503 · ownership.xml · derivative · entry 1

Brun Scott C. · CIK 0001863614 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2035-07-03

F1 · shares: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders.

Read SEC document
July 03, 2025 Filed Jul 3, 2025 20:21 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $6.77 $0.00
Disclosure

SEC source: 0001213900-25-061493 · ownership.xml · derivative · entry 1

WIGGANS THOMAS G · CIK 0001208907 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2035-07-03

F1 · shares: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders.

Read SEC document
July 03, 2025 Filed Jul 3, 2025 20:24 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $6.77 $0.00
Disclosure

SEC source: 0001213900-25-061501 · ownership.xml · derivative · entry 1

EMSTER KURT VON · CIK 0001252524 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2035-07-03

F1 · shares: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders.

Read SEC document
July 03, 2025 Filed Jul 3, 2025 20:20 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $6.77 $0.00
Disclosure

SEC source: 0001213900-25-061492 · ownership.xml · derivative · entry 1

Lucas Svetlana · CIK 0001781292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2035-07-03

F1 · shares: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders.

Read SEC document
July 03, 2025 Filed Jul 3, 2025 20:23 UTC
Nolet ChrisDirector
GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $6.77 $0.00
Disclosure

SEC source: 0001213900-25-061498 · ownership.xml · derivative · entry 1

Nolet Chris · CIK 0001782814 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2035-07-03

F1 · shares: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders.

Read SEC document
July 03, 2025 Filed Jul 3, 2025 20:22 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $6.77 $0.00
Disclosure

SEC source: 0001213900-25-061495 · ownership.xml · derivative · entry 1

Kapoor Vishal · CIK 0001798946 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2035-07-03

F1 · shares: Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 06:30 UTC
MARTELL RONDirector · President and CEO
GrantStock Option (right to buy) · Derivative 234,000 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001213900-25-051729 · ownership.xml · derivative · entry 1

MARTELL RON · CIK 0001177079 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,000

Underlying: Voting Common Stock · 234,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: 1/4th of the shares subject to the retention option shall vest on June 4, 2026 and 1/48th of the shares subject to the retention option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 06:27 UTC
Mahal Jeetinder SinghChief Operating Officer
GrantStock Option (right to buy) · Derivative 90,000 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001213900-25-051726 · ownership.xml · derivative · entry 1

Mahal Jeetinder Singh · CIK 0001882877 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Voting Common Stock · 90,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: 1/4th of the shares subject to the retention option shall vest on June 4, 2026 and 1/48th of the shares subject to the retention option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 06:25 UTC
CROSS HERBChief Financial Officer
GrantStock Option (right to buy) · Derivative 90,000 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001213900-25-051724 · ownership.xml · derivative · entry 1

CROSS HERB · CIK 0001230721 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Voting Common Stock · 90,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: 1/4th of the shares subject to the retention option shall vest on June 4, 2026 and 1/48th of the shares subject to the retention option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
June 04, 2025 Filed Jun 6, 2025 10:23 UTC
Tucker Edwin JonathanChief Medical Officer
GrantStock Option (right to buy) · Derivative 90,000 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001213900-25-051722 · ownership.xml · derivative · entry 1

Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Voting Common Stock · 90,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: 1/4th of the shares subject to the retention option shall vest on June 4, 2026 and 1/48th of the shares subject to the retention option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 17:30 UTC
MARTELL RONDirector · President, CEO and Director
GrantStock Option (right to buy) · Derivative 130,000 $0.00 Strike: $6.20 $0.00
Disclosure

SEC source: 0001213900-25-014950 · ownership.xml · derivative · entry 1

MARTELL RON · CIK 0001177079 · Director · President, CEO and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Voting Common Stock · 130,000 shares

Expires 2035-02-13

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on February 13, 2026, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 17:31 UTC
Mahal Jeetinder SinghChief Operating Officer
GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $6.20 $0.00
Disclosure

SEC source: 0001213900-25-014951 · ownership.xml · derivative · entry 1

Mahal Jeetinder Singh · CIK 0001882877 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Voting Common Stock · 50,000 shares

Expires 2035-02-13

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on February 13, 2026, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 17:30 UTC
CROSS HERBChief Financial Officer
GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $6.20 $0.00
Disclosure

SEC source: 0001213900-25-014949 · ownership.xml · derivative · entry 1

CROSS HERB · CIK 0001230721 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Voting Common Stock · 50,000 shares

Expires 2035-02-13

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on February 13, 2026, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 22:29 UTC
Tucker Edwin JonathanChief Medical Officer
GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $6.20 $0.00
Disclosure

SEC source: 0001213900-25-014948 · ownership.xml · derivative · entry 1

Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Voting Common Stock · 50,000 shares

Expires 2035-02-13

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on February 13, 2026, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
December 12, 2024 Filed Dec 12, 2024 20:02 UTC
Mahal Jeetinder SinghChief Operating Officer
Exercise / conversionStock Option (right to buy) · Derivative 900 $0.00 Strike: $7.10 $0.00
Disclosure

SEC source: 0001213900-24-108551 · ownership.xml · derivative · entry 3

Mahal Jeetinder Singh · CIK 0001882877 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,772

Underlying: Voting Common Stock · 900 shares

Expires 2030-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.

F2 · derivative.exercise_date: 25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter.

Read SEC document
December 12, 2024 Filed Dec 12, 2024 20:02 UTC
Mahal Jeetinder SinghChief Operating Officer
SaleVoting Common Stock 900 $22.11 $19,899.00
Disclosure

SEC source: 0001213900-24-108551 · ownership.xml · nonDerivative · entry 2

Mahal Jeetinder Singh · CIK 0001882877 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,009

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.

Read SEC document
December 12, 2024 Filed Dec 12, 2024 20:02 UTC
Mahal Jeetinder SinghChief Operating Officer
Exercise / conversionVoting Common Stock 900 $7.10 $6,390.00
Disclosure

SEC source: 0001213900-24-108551 · ownership.xml · nonDerivative · entry 1

Mahal Jeetinder Singh · CIK 0001882877 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,909

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.

Read SEC document
September 12, 2024 Filed Sep 12, 2024 17:19 UTC
Mahal Jeetinder SinghChief Operating Officer
Exercise / conversionStock Option (right to buy) · Derivative 900 $0.00 Strike: $7.10 $0.00
Disclosure

SEC source: 0001213900-24-078214 · ownership.xml · derivative · entry 3

Mahal Jeetinder Singh · CIK 0001882877 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,672

Underlying: Voting Common Stock · 900 shares

Expires 2030-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.

F3 · derivative.exercise_date: 25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter.

Read SEC document
September 12, 2024 Filed Sep 12, 2024 17:19 UTC
Mahal Jeetinder SinghChief Operating Officer
SaleVoting Common Stock 900 $21.23 $19,103.67
Disclosure

SEC source: 0001213900-24-078214 · ownership.xml · nonDerivative · entry 2

Mahal Jeetinder Singh · CIK 0001882877 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,009

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.795 to $21.495, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
September 12, 2024 Filed Sep 12, 2024 17:19 UTC
Mahal Jeetinder SinghChief Operating Officer
Exercise / conversionVoting Common Stock 900 $7.10 $6,390.00
Disclosure

SEC source: 0001213900-24-078214 · ownership.xml · nonDerivative · entry 1

Mahal Jeetinder Singh · CIK 0001882877 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,909

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 10:07 UTC GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $23.19 $0.00
Disclosure

SEC source: 0001213900-24-053989 · ownership.xml · derivative · entry 1

Lucas Svetlana · CIK 0001781292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Voting Common Stock · 15,000 shares

Expires 2034-06-18

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on June 18, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
June 12, 2024 Filed Jun 12, 2024 21:40 UTC
Mahal Jeetinder SinghChief Operating Officer
Exercise / conversionStock Option (right to buy) · Derivative 900 $0.00 Strike: $7.10 $0.00
Disclosure

SEC source: 0001213900-24-052215 · ownership.xml · derivative · entry 3

Mahal Jeetinder Singh · CIK 0001882877 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,572

Underlying: Voting Common Stock · 900 shares

Expires 2030-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.

F3 · derivative.exercise_date: 25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter.

Read SEC document
June 12, 2024 Filed Jun 12, 2024 21:40 UTC
Mahal Jeetinder SinghChief Operating Officer
SaleVoting Common Stock 900 $24.16 $21,739.50
Disclosure

SEC source: 0001213900-24-052215 · ownership.xml · nonDerivative · entry 2

Mahal Jeetinder Singh · CIK 0001882877 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,009

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.975 to $24.555, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
June 12, 2024 Filed Jun 12, 2024 21:40 UTC
Mahal Jeetinder SinghChief Operating Officer
Exercise / conversionVoting Common Stock 900 $7.10 $6,390.00
Disclosure

SEC source: 0001213900-24-052215 · ownership.xml · nonDerivative · entry 1

Mahal Jeetinder Singh · CIK 0001882877 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,909

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 16:09 UTC
MARTELL RONDirector · President, CEO and Director
GrantPerformance Restricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-24-052087 · ownership.xml · derivative · entry 2

MARTELL RON · CIK 0001177079 · Director · President, CEO and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Voting Common Stock · 20,000 shares

Expires 2026-06-10

F2 · derivative.exercise_price: Represents a grant of performance-based restricted stock units ("PRSUs"), with each PRSU representing a contingent right to receive one share of common stock of the Issuer.

F3 · derivative.exercise_date: If, by June 10, 2026, the closing price of the Issuer's common stock on the Nasdaq Capital Market is at or above $35.00 per share (subject to adjustment for recapitalizations, stock splits and similar transactions) for thirty consecutive calendar days, all of the shares of the Issuer's common stock subject to the PRSUs shall vest in full on such thirtieth day, so long as the Reporting Person provides continuous services to the Issuer on and through the vesting date, inclusive.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 16:09 UTC
MARTELL RONDirector · President, CEO and Director
GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $23.95 $0.00
Disclosure

SEC source: 0001213900-24-052087 · ownership.xml · derivative · entry 1

MARTELL RON · CIK 0001177079 · Director · President, CEO and Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Voting Common Stock · 10,000 shares

Expires 2034-06-10

F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on June 10, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Read SEC document
June 07, 2024 Filed Jun 10, 2024 22:31 UTC
Tucker Edwin JonathanChief Medical Officer
GrantVoting Common Stock 400 $4.17 $1,669.40
Disclosure

SEC source: 0001213900-24-051417 · ownership.xml · nonDerivative · entry 1

Tucker Edwin Jonathan · CIK 0001792296 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400

F1 · kind: These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 06, 2024 Filed Jun 10, 2024 22:25 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $25.41 $0.00
Disclosure

SEC source: 0001213900-24-051411 · ownership.xml · derivative · entry 1

Shizuru Judith Anne · CIK 0001883000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2034-06-06

Read SEC document
June 06, 2024 Filed Jun 10, 2024 18:30 UTC GrantStock Option (right to buy) · Derivative 7,500 $0.00 Strike: $25.41 $0.00
Disclosure

SEC source: 0001213900-24-051416 · ownership.xml · derivative · entry 1

French Anna Louise · CIK 0001871871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Voting Common Stock · 7,500 shares

Expires 2034-06-06

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.